banner add

New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

from NYT > Health https://ift.tt/MFGJ3z1
via IFTTT

No comments

What R.F.K. Jr.’s Alliance With Trump Could Mean for Public Health

Robert F. Kennedy Jr., who has long voiced doubts about vaccine safety, has hopes of influencing federal health policy. Could he finally get...

Theme images by PLAINVIEW. Powered by Blogger.